FDA docket cites a 2022 study about acetaminophen in breast milk, it touches infant feeding not grocery shelves
FDA added a 2022 study on acetaminophen in human milk to a public docket; it is background material with no immediate policy change.
By Foodie Pundit Newsroom - Published - Section: Policy Regulation
Key points
- FDA added a 2022 pediatric study about acetaminophen in breast milk to a public docket on 2026-08-19.
- The entry is background material, not a new rule or guidance, so it does not change labels or grocery shelves right now.
- The record ties into the food chain at the point where human milk is nutrition, but the path to consumer prices or menus is indirect.
- No lobbying money or filer is listed in the docket entry; the record shows none disclosed.
- If you are breastfeeding and worried about medication, talk to your pediatrician; the docket just flags research, it does not give medical advice.
This report is part of Foodie Pundit premium coverage. Foodie Pundit members read the full story. See membership.
More from the Foodie Pundit Newsroom
- A tiny new Washington wine region shows up on labels, and yes it could change what you order
- EPA finalizes limits for carboxin residues on crops, a farm to fork regulatory step
- EPA proposes settlement over delay on neonics tolerance petition, a paper move that could matter for how residues are regulated
- Marcus Samuelsson Reinvents Home Cooking As Restaurant Costs Drive Consumers To The Kitchen
- Marcus Samuelsson Takes On Takeout Market With Home Cooking Playbook